Equities analysts expect Synopsys, Inc. (NASDAQ:SNPS) to post earnings per share of $0.73 for the current quarter, according to Zacks Investment Research. Four analysts have made estimates for Synopsys’ earnings. The highest EPS estimate is $0.77 and the lowest is $0.69. Synopsys reported earnings per share of $1.66 in the same quarter last year, which would suggest a negative year-over-year growth rate of 56%. The company is expected to announce its next earnings results on Wednesday, December 4th.
On average, analysts expect that Synopsys will report full-year earnings of $3.15 per share for the current year, with EPS estimates ranging from $3.11 to $3.19. For the next year, analysts forecast that the company will report earnings of $3.45 per share, with EPS estimates ranging from $3.23 to $3.57. Zacks Investment Research’s earnings per share averages are an average based on a survey of sell-side analysts that follow Synopsys.
Synopsys (NASDAQ:SNPS) last posted its earnings results on Wednesday, August 21st. The semiconductor company reported $0.65 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.62 by $0.03. The company had revenue of $853.00 million for the quarter, compared to analyst estimates of $831.03 million. Synopsys had a net margin of 18.94% and a return on equity of 16.56%. The business’s revenue for the quarter was up 9.5% compared to the same quarter last year. During the same period last year, the business posted $0.95 earnings per share.
In related news, VP Sudhindra Kankanwadi sold 8,011 shares of the firm’s stock in a transaction on Thursday, September 5th. The shares were sold at an average price of $144.30, for a total transaction of $1,155,987.30. Following the sale, the vice president now directly owns 8,663 shares in the company, valued at $1,250,070.90. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Steven Walske sold 2,453 shares of the firm’s stock in a transaction on Friday, June 28th. The stock was sold at an average price of $126.54, for a total transaction of $310,402.62. Following the sale, the director now owns 14,038 shares in the company, valued at $1,776,368.52. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 51,881 shares of company stock worth $6,932,729. 1.84% of the stock is currently owned by company insiders.
Several large investors have recently modified their holdings of the stock. Next Capital Management LLC acquired a new stake in Synopsys in the 2nd quarter valued at $26,000. Hanseatic Management Services Inc. acquired a new stake in Synopsys in the 1st quarter valued at $30,000. Ruggie Capital Group acquired a new stake in Synopsys in the 2nd quarter valued at $32,000. Virtus ETF Advisers LLC acquired a new stake in Synopsys in the 2nd quarter valued at $34,000. Finally, Arcadia Investment Management Corp MI acquired a new stake in Synopsys in the 2nd quarter valued at $42,000. Institutional investors and hedge funds own 89.28% of the company’s stock.
SNPS opened at $133.21 on Tuesday. The firm’s fifty day moving average is $134.72 and its two-hundred day moving average is $124.00. The company has a debt-to-equity ratio of 0.03, a quick ratio of 0.90 and a current ratio of 0.99. The firm has a market cap of $20.23 billion, a PE ratio of 47.24, a price-to-earnings-growth ratio of 3.61 and a beta of 1.23. Synopsys has a twelve month low of $79.14 and a twelve month high of $146.66.
Synopsys Company Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits (ICs). It offers Fusion Design Platform, a digital design implementation solution; Verification Continuum Platform, which provides virtual prototyping, static and formal verification, simulation, emulation, field-programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Read More: What is a portfolio manager?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.